| Term 
 
        | Metabolism, Biotransformation, Bioconversion   = |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Foreign biotics or foreign drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | To induce; stimulate chemically |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 1. Biotransformations are summed as _________.   2. Resulting products are called ___________.   3. What is the goal for metabolism? |  | Definition 
 
        | 1. metabolism   2. metabolites   3. Transform lipophilic molecules into hydrophilic ones so that they can be eliminated |  | 
        |  | 
        
        | Term 
 
        | Parent molecule -->   Phase 1 metabolite -->   Parent molecule -->   Phase 2 metabolite --> |  | Definition 
 
        | Parent molecule -->Phase 1 metabolism   Phase 1 metabolite --> Phase 2 metabolism   Parent molecule --> Phase 2 metabolism   Phase 2 metabolite --> Phase 1 metabolism |  | 
        |  | 
        
        | Term 
 
        | Drugs withdrawn due to reactive metabolism |  | Definition 
 
        | 1. Benoxaprofen   2. Iproniazid   3. Nefazodone   4. Tienillic acid   5. Troglitazone   6. Bromfenac, unclear |  | 
        |  | 
        
        | Term 
 
        | Drugs with Black Box Warnings; 8 of 15 have reactive metabolites |  | Definition 
 
        | 1. Decarbazine 2. Dantrolene 3. Felbamate 4. Flutamide 5. Isoniazid 6. Ketoconazole 7. Tolcapone 8. Valproic acid   Reactive metabolites: Acitretin, Bosentan, Gemtuzumab, Ozogamicin, Naltrexone, Nevirapine, Pemoline, Trovafloxacine |  | 
        |  | 
        
        | Term 
 
        | Drugs whose reactive metabolites have warnings of precautions of heptatoxicity |  | Definition 
 
        | 1. Acetaminophen 2. Carbamazepine 3. Clozapine 4. Diclofenac 5. Disulfiram 6. Halothane 7. Lefunomide 8. Methyldopa 9. Rifampin 10. Tacrin 11. Tamoxifen 12. Terbinafine 13. Ticlopidine 14. Zileuton |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Liver (major site) 2. Small Intestine 3. Kidney 4. Skin 5. Lungs (& nasal passage) 6. Plasma |  | 
        |  | 
        
        | Term 
 
        | Cellular sites of metabolism |  | Definition 
 
        | 1. Microsomal (Endoplasmic Reticulum) 2. Cytosol 3. Mitochondrial |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Termination of Drug Action 2. Activation of prodrug 3. Synthesis of similarly active compounds 4. Metabolite with altered activity 5. Bioactivation and toxication 6. Carcinogenesis 7. Tetratogenesis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Termination of Drug Action |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Termination of Drug Action |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activation of Prodrug Beta-lactam double-ester prodrug |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bioactivation and Toxication |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bioactivation and Toxication |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthesis of similarly active compounds |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthesis of similarly active compounds |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthesis of similarly active compounds |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Synthesis of Similarly active compounds |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metabolites with altered activity |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carcinogenesis Procarcinogens/toxins activated by CYP450s |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetratogenesis   R,S Thalidomide   Initially used as a sedative & antimimetic Now: leprosy and anticancer |  | 
        |  | 
        
        | Term 
 
        | Drug Drug Interactions   Some drugs can ______ the synthesis of CYP450 isozymes, hence accelerate the _____________ of drugs utilizing those metabolic pathways and ____________ their plasma levels.   What are the common CYP Inducers?   Ex: Rifampin __ , CYP ___ --> __ HIV protease inhibitors in plasma |  | Definition 
 
        | Some drugs can induce the synthesis of CYP450 isozymes, hence accelerate the clearance of drugs utilizing those metabolic pathways and decrease their plasma levels.   1. Phenobarbital 2. Rifampin 3. Carbamazepine   Rifampin increase, CYP increase --> Decrease  HIV protease inhibitors in plasma |  | 
        |  | 
        
        | Term 
 
        | Drug Drug Interactions   _______ of CYP isozymes, ______ removal of drugs from systemic circulation leading to _______ drug levels because their metabolism is __________.   Common CYP inhibitors: ______, _______,_______   Ex: Omeprazole _____, CYP _____ --> ___ warfarin plasma concentration |  | Definition 
 
        | Inhibitors  of CYP isozymes, decrease removal of drugs from systemic circulation leading to increase drug levels because their metabolism is inhibited.   1. Erythromycin 2. Ketoconazole 3. Omeprazole   Ex. Omeprazole decreases, CYP decreases --> increases warfarin plasma concentration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Ethanol 2. phenobarbital 3.Rifampin 4. Smoking |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Cimetidine 2. Erythromycin 3. Grapefruit juice 4. Ketoconazole 5. Quinidine 6. Omeprazole |  | 
        |  |